Product Details
Avastin 100 mg**
Bevacizumab100 mg/4 mL
Concentrate for solution for infusion
ROA
Intravenous
Applicant Name
Roche Products Limited
NRN
A6-0123
Status
Active
Composition
Each 4-mL multiple dose vial contains 100 mg Bevacizumab. Bevacizumab (manufactured by recombinant DNA technology using CHO [Chinese hamster ovary] cells) Excipient: Each mL of concentrate contains 1.35 mg Sodium, i.e. 5.42 mg or 21.67 mg per multiple dose vial
ATC Code
L01FG01
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
4 mL x 1's (in single-dose vial)
Product Description
Concentrate for solution for infusion in 4-mL single dose colourless glass vial. Clear to slightly opalescent, colourless to pale brown sterile fluid for intravenous infusion
Manufacturer Name
F. Hoffmann-La Roche Ltd
Manufacturer Country
SWITZERLAND
Approval Date
2023-02-26
Expiry Date
2028-02-22